About
Edwards Lifesciences is a global medical technology company focused on innovative solutions for structural heart disease and critical care. Founded in 1958 by Miles “Lowell” Edwards, the company has a strong legacy in developing heart valve technologies and advanced hemodynamic monitoring systems. With a presence in approximately 100 countries and around 8,500 employees, Edwards Lifesciences is dedicated to improving patient lives through partnerships with clinicians. The company’s product portfolio includes surgical valve technologies, transcatheter heart valves, transcatheter mitral and tricuspid therapies, and critical care monitoring products. Notably, Edwards pioneered the transcatheter aortic valve replacement (TAVR) procedure, which allows for valve replacement without open-heart surgery. Their innovations target patients with advanced cardiovascular disease, providing essential solutions for heart valve repair and replacement, as well as critical care management. Edwards Lifesciences is committed to research and development, aiming to enhance the quality of life for patients worldwide.
Technologies
Keywords
Company Information
-
Employees 16000
-
Founded 1958
-
Annual Revenue $5439500000
-
Total Funding $315141202
Location
1 Edwards Way, Irvine, California, United States, 92614
